Casey-M-1982-Phd-Thesis.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Green Synthetic Approach to 5-Substituted-1H-Tetrazoles Via Recycle and Reuse of Tributyltin Chloride
Asian Journal of Chemistry; Vol. 25, No. 1 (2013), 393-396 http://dx.doi.org/10.14233/ajchem.2013.13106 Green Synthetic Approach to 5-Substituted-1H-Tetrazoles via Recycle and Reuse of Tributyltin Chloride 1,* 2 1 3 A. SAMPATH , V. PRABHAKAR REDDY , A. KALYAN CHAKRAVARTHY and P. PRATAP REDDY 1Research and Development, Integrated Product Development, Innovation Plaza, Dr Reddy's Laboratories Ltd., Survey Nos. 42, 45, 46 and 54, Bachupally, Qutubullapur, Ranga Reddy District-500 123, India 2Department of Chemistry, P.G. College of Science, Osmania University, Saifabad, Hyderabad-500 004, India 3Research and Development, Macleods Pharmaceuticals Limited, G-2, Mahakali Caves Road, Andheri (E), Mumbai-400 093, India *Corresponding author: E-mail: [email protected] (Received: 25 November 2011; Accepted: 28 July 2012) AJC-11886 A simple, safe and efficient process for the recycle of tributyltin chloride from tributyltin hydroxide is developed and its reuse in the synthesis of 5-substituted-1H-tetrazoles is successfully demonstrated, which paved a way to reduce the toxic tin waste significantly. Recycling of tributyltin chloride is possible over six cycles without loss of its activity. Key Words: 5-Substituted-1H-tetrazole, [3+2] Cycloaddition, Nitrile, Recycle, Tributyltin chloride, Tributyltin hydroxide. INTRODUCTION fluorous tin bromide, used in the preparation of tetrazoles as fluorous tin chloride by acidic hydrolysis of stannyl tetrazole. The nitrogen-rich tetrazole moiety is an integral part of But the usage of fluorous tin bromide is commercially not 1 several molecules, which find application as propellants , viable, as it is more expensive than tributyltin chloride. More- 2 3 explosives and pharmaceuticals . -
Download Author Version (PDF)
Organic & Biomolecular Chemistry Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/obc Page 1 of 10 OrganicPlease & doBiomolecular not adjust margins Chemistry Journal Name ARTICLE Steering the Azido-Tetrazole Equilibrium of 4-Azidopyrimidines via Substituent Variation – Implications for Drug Design and Received 00th January 20xx, Azide-Alkyne Cycloadditions Accepted 00th January 20xx Manuscript a b c ,a ,a,d DOI: 10.1039/x0xx00000x A. Thomann, J. Zapp, M. Hutter, M. Empting* and R. W. Hartmann* www.rsc.org/ This paper focuses on an interesting constitutional isomerism called azido-tetrazole equilibrium which is observed in azido- substituted N-heterocycles. We present a systematic investigation of substituent effects on the isomer ratio within a 2- substituted 4-azidopyrimidine model scaffold. -
Synthesis of 5-Substituted 1H-Tetrazoles from Nitriles And
Angewandte Chemie DOI: 10.1002/anie.201003733 Microreactors Synthesis of 5-Substituted 1H-Tetrazoles from Nitriles and Hydrazoic Acid by Using a Safe and Scalable High-Temperature Microreactor Approach** Bernhard Gutmann, Jean-Paul Roduit, Dominique Roberge,* and C. Oliver Kappe* Dedicated to Professor K. Barry Sharpless Interest in tetrazole chemistry over the past few years has have been introduced as comparatively safe azide sources been increasing rapidly, mainly as a result of the role played (sometimes prepared in situ), that have the added benefit of by this heterocyclic functionality in medicinal chemistry as a being soluble in organic solvents. Unfortunately, with very metabolically stable surrogate for carboxylic acid function- few exceptions, all of these methods require long reaction alities.[1] Additional important applications for tetrazoles are times (several hours to days) in combination with high found in coordination chemistry, materials science, and as reaction temperatures. intermediates in a variety of synthetic transformations.[2] Based on atom economy and environmental impact, the The most common synthetic approach to prepare conceptually most straightforward approach to the tetrazole 5-substituted 1H-tetrazole derivatives involves the addition nucleus involves the direct addition of hydrazoic acid (HN3) of azide salts to organic nitriles in a temperature range of to organic nitriles, first attempted in 1932.[15] Unfortunately, [1,2] typically 100–1508C (Scheme 1). A plethora of synthetic HN3 is extremely toxic (comparable to HCN) and owing to the explosive nature and low boiling point (378C) of this high- [16] energy material procedures involving free HN3 have not found any practical application in tetrazole synthesis so far. -
United States Patent Office Patented Apr
3,505,222 United States Patent Office Patented Apr. 7, 1970 1. 2 3,505,222 product of a mercaptain with sulfur trioxide. Their metal LUBRICANT COMPOSITIONS salts are represented by the formula: Leonard M. Niebylski, Birmingham, Mich, assignor to O Ethyl Corporation, New York, N.Y., a corporation of Virginia (R-S-S-0--M No Drawing. Filed Mar. 29, 1967, Ser. No. 626,701 5 s (I) Int. C. C10m 5/14, 3/18, 7/36 wherein R is a hydrocarbon radical containing from 1 U.S. C. 252-17 2 Claims to about 30 carbon atoms, M is a metal, and n is the valence of metal M. For example, when M is the monova 0. lent sodium ion, n is 1. ABSTRACT OF THE DISCLOSURE The radical R can be an alkyl, cycloalkyl, aralkyl, The extreme pressure wear properties of base lubri alkaryl, or aryl radical. The radicals may contain other cants including water, hydrocarbons, polyesters, silicones, nonhydrocarbon substituents such as chloro, bromo, iodo, polyethers and halocarbons is enhanced by the addition fluoro, nitro, hydroxyl, nitrile, isocyanate, carboxyl, car of a synergistic mixture of a thiosulfate compound and 15 bonyl, and the like. a lead compound. The useful metals are all those capable of forming Bunte salts. Preferred metals are those previously listed as suitable for forming metal thiosulfates. Of these, the Background more preferred metals are sodium and lead, and lead is 20 the most preferred metal in the Bunte salts. This invention relates to improved lubricant composi Examples of useful Bunte salts include: tions. -
University of California Riverside
UNIVERSITY OF CALIFORNIA RIVERSIDE Natamycin, a New Postharvest Biofungicide: Toxicity to Major Decay Fungi, Efficacy, and Optimized Usage Strategies A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Plant Pathology by Daniel Sungen Chen September 2020 Dissertation Committee: Dr. James E. Adaskaveg, Chairperson Dr. Michael E. Stanghellini Dr. Alexander I. Putman Copyright by Daniel Sungen Chen 2020 The Dissertation of Daniel Sungen Chen is approved: Committee Chairperson University of California, Riverside AKNOWLEDGEMENTS Foremost, I thank my mentor Dr. James E. Adaskaveg for accepting me into his research program and teaching me the intricacies of the field of postharvest plant pathology and preparing me for a bright career ahead. His knowledge of the field is unmatched. A special thanks goes out to Dr. Helga Förster, whose expertise and attention to detail has helped me out tremendously in my research and writings. I thank my dissertation committee members, Dr. Michael Stanghellini and Dr. Alexander Putman, for their time spent reviewing my dissertation and their guidance during the pursuit of my doctoral degree. Special thanks also go out to my lab members Dr. Rodger Belisle, Dr. Wei Hao, Dr. Kevin Nguyen, and Nathan Riley for their companionship and much appreciated help with my projects. I would also like to thank my former laboratory members, Dr. Stacey Swanson and Dr. Morgan Thai for their guidance and help during the early years of my graduate program. Thanks go out to Dr. Lingling Hou, Dr. Yong Luo, and Doug Cary for their assistance with performing experimental packingline studies at the Kearney Agricultural Research and Extension Center. -
Nitrosamines EMEA-H-A5(3)-1490
25 June 2020 EMA/369136/2020 Committee for Medicinal Products for Human Use (CHMP) Assessment report Procedure under Article 5(3) of Regulation EC (No) 726/2004 Nitrosamine impurities in human medicinal products Procedure number: EMEA/H/A-5(3)/1490 Note: Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ...................................................................................... 2 1. Information on the procedure ............................................................... 7 2. Scientific discussion .............................................................................. 7 2.1. Introduction......................................................................................................... 7 2.2. Quality and safety aspects ..................................................................................... 7 2.2.1. Root causes for presence of N-nitrosamines in medicinal products and measures to mitigate them............................................................................................................. 8 2.2.2. Presence and formation of N-nitrosamines -
Updates in Ocular Antifungal Pharmacotherapy: Formulation and Clinical Perspectives
Current Fungal Infection Reports (2019) 13:45–58 https://doi.org/10.1007/s12281-019-00338-6 PHARMACOLOGY AND PHARMACODYNAMICS OF ANTIFUNGAL AGENTS (N BEYDA, SECTION EDITOR) Updates in Ocular Antifungal Pharmacotherapy: Formulation and Clinical Perspectives Ruchi Thakkar1,2 & Akash Patil1,2 & Tabish Mehraj1,2 & Narendar Dudhipala1,2 & Soumyajit Majumdar1,2 Published online: 2 May 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review In this review, a compilation on the current antifungal pharmacotherapy is discussed, with emphases on the updates in the formulation and clinical approaches of the routinely used antifungal drugs in ocular therapy. Recent Findings Natamycin (Natacyn® eye drops) remains the only approved medication in the management of ocular fungal infections. This monotherapy shows therapeutic outcomes in superficial ocular fungal infections, but in case of deep-seated mycoses or endophthalmitis, successful therapeutic outcomes are infrequent, as a result of which alternative therapies are sought. In such cases, amphotericin B, azoles, and echinocandins are used off-label, either in combination with natamycin or with each other (frequently) or as standalone monotherapies, and have provided effective therapeutic outcomes. Summary In recent times, amphotericin B, azoles, and echinocandins have come to occupy an important niche in ocular antifungal pharmacotherapy, along with natamycin (still the preferred choice in most clinical cases), in the management of ocular fungal infections. -
Magnetic Graphene Oxide Modified by Chloride Imidazole Ionic Liquid For
RSC Advances View Article Online PAPER View Journal | View Issue Magnetic graphene oxide modified by chloride imidazole ionic liquid for the high-efficiency Cite this: RSC Adv.,2017,7,9079 adsorption of anionic dyes† Huan Wangab and Yinmao Wei*a Magnetic graphene oxide modified with 1-amine-3-methyl imidazole chloride ionic liquid (LI-MGO) was prepared through chemical co-precipitation and modified using 1-amine-3-imidazolium chloride ionic liquid. The as-prepared LI-MGO was characterized using X-ray diffraction (XRD), transmission electron microscopy (TEM) and Fourier transform infrared spectrometry (FT-IR). The adsorption properties were evaluated through adsorption experiments with two kinds of anionic dyes, orange IV (OIV) and glenn black R (GR) and two kinds of cationic dyes, acridine orange (AO) and crystal violet (CV). The results indicated that the adsorption data fitted the Langmuir isotherm and followed pseudo-second-order kinetics. The maximum adsorption capacities for GR, OIV, AO and CV were 588.24, 57.37, 132.80 and Received 29th November 2016 À1 Creative Commons Attribution 3.0 Unported Licence. 69.44 mg g at 298 K, respectively. LI-MGO has better selective adsorption for anionic dyes than Accepted 17th January 2017 magnetic graphene oxide (MGO) due to electrostatic interactions. Moreover, the LI-MGO adsorbent can DOI: 10.1039/c6ra27530c be magnetic separated and is easy to prepare. It demonstrated that LI-MGO would have great potential rsc.li/rsc-advances as an efficient environmentally friendly adsorbent for the removal of anionic -
Safety Data Sheet - Version 5.0 Preparation Date 9/22/2016 Latest Revision Date (If Revised) SDS Expiry Date 9/21/2019
Safety Data Sheet - Version 5.0 Preparation Date 9/22/2016 Latest Revision Date (If Revised) SDS Expiry Date 9/21/2019 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1 Product Identifier Chemical Name 1-Triphenylmethyl-5-[4'-(bromomethyl)biphenyl-2-yl]tetrazole Catalogue # T808965 1.2 Relevant Identified Uses of the Substance or Mixture and Uses Advised Against Product Uses To be used only for scientific research and development. Not for use in humans or animals. 1.3 Details of the Supplier of the Safety Data Sheet Company Toronto Research Chemicals 2 Brisbane Road Toronto, ON M3J 2J8 CANADA Telephone +14166659696 FAX +14166654439 Email [email protected] 1.4 Emergency Telephone Number Emergency# +14166659696 between 0800-1700 (GMT-5) 2. HAZARDS IDENTIFICATION WHMIS Classification (Canada) WHMIS Symbols (Canada) D1B Toxic Material Causing Immediate and Serious Toxic Effects Toxic by Ingestion D2B Toxic Material Causing Other Toxic Effects Moderate Skin/Eye Irritant 2.1/2.2 Classification of the Substance or Mixture and Label Elements GHS Hazards Classification (According to EU Regulation 1272/2008 and US OSHA 1910.1200) Acute Toxicity, Oral (Category 3) Skin Irritation (Category 2) Serious Eye Irritation (Category 2A) EU Classification (According to EU Regulation 67/548/EEC) Toxic if swallowed. Irritating to eyes and skin. EU Risk and Safety Statements (According to EU Regulation 67/548/EEC) Hazard Statements Hazard Codes Toxic T Risk Codes and Phrases R25 Toxic if swallowed. R36/38 Irritating to eyes and skin. Safety Precaution Codes and Phrases S36/37/39 Wear suitable protective clothing, gloves and eye/face protection. -
Synthesis of Photoreactive Imidazole Derivatives and Thermal Curing Reaction of Epoxy Resins Catalyzed by Photo-Generated Imidazole
Polymer Journal, Vol. 29, No. 5, pp 450-456 (1997) Synthesis of Photoreactive Imidazole Derivatives and Thermal Curing Reaction of Epoxy Resins Catalyzed by Photo-Generated Imidazole Tadatomi NrsHIKUBO,t Atsushi KAMEYAMA, and Yoshiyasu TOYA Department of' Applied Chemistry, Faculty of Engineering, Kanagawa University, Rokkakubashi, Kanagawa-ku, Yokohama, 221 Japan (Received November 6, 1996) ABSTRACT: Photoreactive blocked imidazoles such as N-(2-nitrobenzyloxycarbonyl)imidazole (2-NBCI), N-(3-nitro benzyloxycarbonyl)imidazole (3-NBCI), N-( 4-nitrobenzyloxycarbonyl)imidazole (4- NBCI), N-( 4-chloro-2-nitro benzyloxy carbonyl )imidazole (CNBCI), N-(5-methyl-2-nitrobenzyloxycarbonyl)imidazole (MNBCI), and N-(4,5-dimethoxy-2-ni trobenzyloxycarbonyl)imidazole (DNBCI) were synthesized in good yields by reactions of N,N'-carbonyldiimidazole (CDI) with corresponding benzyl alcohols. The prepared 2-NBCI decomposed smoothly to produce imidazole by UV-irradiation in tetrahydrofuran (THF) solution or poly(methyl methacrylate) (PMMA) film. Rates of photolysis of DNBCI, MNBCI and CNBCI were higher than that of 2-NBCI in PMMA film, although the rates of 3-NBCI and 4-NBCI were slower than that of 2-NBCI in PMMA film under the same conditions. Thermal curing reactions of epoxy resins and poly(glycidyl methacrylate-co-methyl methacrylate) [P(GMA55-MMA45)] using photo-generated imidazole were examined at I00-160°C. The ring opening reaction of epoxide groups, confirmed by IR spectra, in epoxy resins and P(GMA55-MMA45) proceeded smoothly by catalysis of the photo-generated imidazole. KEY WORDS Synthesis of Blocked Imidazole /Photo-Generation/ Imidazole / Thermal Curing Reaction / Epoxy Resin/ Poly(glycidyl methacrylate-co-methyl methac!ylate) / Epoxy resins are typical thermo-setting resins, and Tsunooka et al. -
Chemical Innovation Technologies to Make Processes and Products More Sustainable
United States Government Accountability Office Center for Science, Technology, and Engineering Natural Resources and Environment Report to Congressional Requesters February 2018 TECHNOLOGY ASSESSMENT Chemical Innovation Technologies to Make Processes and Products More Sustainable GAO-18-307 The cover image displays a word cloud generated from the transcript of the meeting we convened with 24 experts in the field of sustainable chemistry. The size of the words in the cloud corresponds to the frequency with which each word appeared in the transcript. In most cases, similar words—such as singular and plural versions of the same word— were combined into a single term. Words that were unrelated to the topic of sustainable chemistry were removed. The images around the periphery are stylized representations of chemical molecules that seek to illustrate a new conceptual framework, whereby molecules can be transformed to provide better performance; however, they are not intended to represent specific chemical compounds. TECHNOLOGY ASSESSMENT Highlights of GAO-18-307, a report to congressional requesters Chemical Innovation February 2018 Technologies to Make Processes and Products More Sustainable Why GAO did this study What GAO found Chemistry contributes to virtually every Stakeholders lack agreement on how to define sustainable chemistry and how to aspect of modern life and the chemical measure or assess the sustainability of chemical processes and products; these industry supports more than 25 percent differences hinder the development and adoption of more sustainable chemistry of the gross domestic product of the technologies. However, based on a review of the literature and stakeholder United States. While these are positive interviews, GAO identified several common themes underlying what sustainable contributions, chemical production can chemistry strives to achieve, including: have negative health and environmental · improve the efficiency with which natural resources—including energy, consequences. -
Imidazole, Triazole and Tetrazole Derivatives Imidazol-, Triazol- Und Tetrazolderivate Derives D'imidazole, Triazole Et Tetrazole
Europaisches Patentamt (19) European Patent Office Office europeenpeen des brevets EP0497 512B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) intci.6: C07D 403/06, C07D 403/04, of the grant of the patent: C07D 409/04, C07D 401/14, 24.09.1997 Bulletin 1997/39 C07D 403/14, A61K 31/41 (21) Application number: 92300617.5 (22) Date of filing: 24.01.1992 (54) Imidazole, triazole and tetrazole derivatives Imidazol-, Triazol- und Tetrazolderivate Derives d'imidazole, triazole et tetrazole (84) Designated Contracting States: (74) Representative: Thompson, John Dr. et al AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE Merck & Co., Inc. European Patent Department (30) Priority: 01.02.1991 GB 9102222 Terlings Park 03.04.1991 GB 9106917 Eastwick Road 21.06.1991 GB 9113415 Harlow, Essex CM20 2QR (GB) 23.10.1991 GB 9122451 (56) References cited: (43) Date of publication of application: EP-A- 0 200 322 EP-A- 0 313 397 05.08.1992 Bulletin 1992/32 WO-A-91/18897 (60) Divisional application: 97200467.5 JOURNAL OF MEDICINAL CHEMISTRY, vol. 30, no. 1, January 1987, WASHINGTON US pages 1 (73) Proprietor: MERCK SHARP & DOHME LTD. - 12 R. A. GLENN 'Central Serotonin Receptors Hoddesdon Hertfordshire EN11 9BU (GB) as Targets for Drug Research' (72) Inventors: Remarks: • Baker, Raymond The file contains technical information submitted Much Hadham, Hertfordshire (GB) after the application was filed and not included in this • Matassa, Victor G. specification Furneux Pelham, Hertfordshire (GB) • Street, Leslie J. Harlow, Essex (GB) DO CM lo O) ^- Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice the Patent Office of the Notice of shall be filed in o to European opposition to European patent granted.